The effectiveness and safety of cariprazine in schizophrenia patients with negative symptoms and insufficient effectiveness of previous antipsychotic therapy: an observational study-Reference-Cited by-同舟云学术

The effectiveness and safety of cariprazine in schizophrenia patients with negative symptoms and insufficient effectiveness of previous antipsychotic therapy: an observational study

Published:2021-02-05 Issue:3 Volume:36 Page:154-161
ISSN:0268-1315
Container-title:International Clinical Psychopharmacology
language:en
Short-container-title:

Author:

Rancans Elmars,Dombi Zsófia Borbála,Mátrai Péter,Barabássy Ágota,Sebe Barbara,Skrivele Iveta,Németh György

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Psychiatry and Mental health

Reference45 articles.

1. Cross-cultural validation of the 5-factor structure of negative symptoms in schizophrenia;Ahmed;Schizophr Bull,2019

2. Principles and methods of validity and reliability testing of questionnaires used in social and health science researches;Bolarinwa;Niger Postgrad Med J,2015

3. Categorizing and assessing negative symptoms;Bucci;Curr Opin Psychiatry,2017

4. Pharmacological treatment of negative symptoms in schizophrenia: update and proposal of a clinical algorithm;Cerveri;Neuropsychiatr Dis Treat,2019

5. Why do we need observational studies of everyday patients in the real-life setting?;Cohen;Eur Heart J Suppl,2015

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Navigating Schizophrenia Treatment: Balancing Symptom Relief and Long-Term Needs;New Approaches to the Management and Diagnosis of Schizophrenia [Working Title];2024-05-29

2. Cariprazine Orodispersible Tablet: A New Formulation for Cariprazine;Pharmacopsychiatry;2024-05-06

3. A review on the pharmacology of cariprazine and its role in the treatment of negative symptoms of schizophrenia;Frontiers in Psychiatry;2024-04-22

4. Pharmacotherapy of schizophrenia: clinical and some age-related aspects;S.S. Korsakov Journal of Neurology and Psychiatry;2024

5. Focus on antipsychotics and related therapeutic drug monitoring;International Clinical Psychopharmacology;2023-11-19